410 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
include: the Company’s ability to secure significant additional capital as and when needed; the Company’s ability to achieve the intended benefits
8-K
EX-2.1
wb777zeh
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-4.1
6z9q 0fmxas
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
pgsem qs26
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
py0124p6wssk
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
c0vmce07j6y0 5a5
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
zuddmmwnz
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-10.1
1gtafikngbzhds5rq
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-1.1
1v78vu9
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
2r519rk
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
8h8rr
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm